Stay updated on Tolvaptan in Pediatric ADPKD: Safety, PK, Efficacy Clinical Trial
Sign up to get notified when there's something new on the Tolvaptan in Pediatric ADPKD: Safety, PK, Efficacy Clinical Trial page.

Latest updates to the Tolvaptan in Pediatric ADPKD: Safety, PK, Efficacy Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.4.3 was added to the page history, replacing the previous v3.4.2.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedA new Revision: v3.4.2 was added to the history, and the older Notice about funding and Revision: v3.4.1 entry were removed.SummaryDifference0.7%

- Check41 days agoChange DetectedA government funding notice banner was added and the site revision tag updated to v3.4.1, replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check48 days agoChange DetectedA glossary toggle (Show glossary) and color-coded change indicators were added to the history view, while the No FEAR Act Data label and the older Revision: v3.3.4 text were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check56 days agoChange DetectedA new revision entry v3.3.4 was added and an older entry v3.3.3 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check84 days agoChange DetectedRevision: v3.3.3 was added to the history. The HHS Vulnerability Disclosure entry (Revision: v3.3.2) was removed.SummaryDifference0.2%

Stay in the know with updates to Tolvaptan in Pediatric ADPKD: Safety, PK, Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tolvaptan in Pediatric ADPKD: Safety, PK, Efficacy Clinical Trial page.